IONS logo

Ionis Pharmaceuticals, Inc. (IONS) Cash From Investing

Annual CFI:

-$134.03M+$80.10M(+37.41%)
December 31, 2024

Summary

  • As of today, IONS annual cash from investing is -$134.03 million, with the most recent change of +$80.10 million (+37.41%) on December 31, 2024.
  • During the last 3 years, IONS annual cash from investing has fallen by -$328.93 million (-168.76%).
  • IONS annual cash from investing is now -148.83% below its all-time high of $274.48 million, reached on December 31, 2020.

Performance

IONS Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONScash flow metrics

Quarterly CFI:

$91.34M+$211.41M(+176.07%)
September 1, 2025

Summary

  • As of today, IONS quarterly cash from investing is $91.34 million, with the most recent change of +$211.41 million (+176.07%) on September 1, 2025.
  • Over the past year, IONS quarterly cash from investing has increased by +$432.13 million (+126.80%).
  • IONS quarterly cash from investing is now -66.72% below its all-time high of $274.48 million, reached on December 31, 2020.

Performance

IONS Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONScash flow metrics

TTM CFI:

$209.94M+$432.13M(+194.49%)
September 1, 2025

Summary

  • As of today, IONS TTM cash from investing is $209.94 million, with the most recent change of +$432.13 million (+194.49%) on September 1, 2025.
  • Over the past year, IONS TTM cash from investing has increased by +$438.89 million (+191.70%).
  • IONS TTM cash from investing is now -53.17% below its all-time high of $448.34 million, reached on March 31, 2021.

Performance

IONS TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONScash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

IONS Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+37.4%+126.8%+191.7%
3Y3 Years-168.8%+149.7%+155.3%
5Y5 Years-224.7%+496.5%+51.9%

IONS Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-168.8%+49.0%-57.0%+126.8%at high+155.3%
5Y5-Year-148.8%+49.0%-66.7%+126.8%-53.2%+155.3%
All-TimeAll-Time-148.8%+85.6%-66.7%+124.3%-53.2%+119.5%

IONS Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
$91.34M(+176.1%)
$209.94M(+194.5%)
Jun 2025
-
-$120.07M(-170.4%)
-$222.19M(-460.1%)
Mar 2025
-
$170.46M(+149.9%)
-$39.67M(+70.4%)
Dec 2024
-$134.03M(+37.4%)
$68.21M(+120.0%)
-$134.03M(+41.5%)
Sep 2024
-
-$340.80M(-645.7%)
-$228.95M(-226.8%)
Jun 2024
-
$62.45M(-17.9%)
$180.55M(-3.8%)
Mar 2024
-
$76.11M(+384.9%)
$187.62M(+187.6%)
Dec 2023
-$214.13M(+18.5%)
-$26.71M(-138.9%)
-$214.13M(-965.8%)
Sep 2023
-
$68.71M(-1.2%)
$24.73M(+110.9%)
Jun 2023
-
$69.52M(+121.3%)
-$227.91M(+24.2%)
Mar 2023
-
-$325.64M(-253.5%)
-$300.73M(-14.5%)
Dec 2022
-$262.64M(-234.8%)
$212.15M(+215.3%)
-$262.64M(+30.8%)
Sep 2022
-
-$183.93M(-5466.9%)
-$379.67M(-414.7%)
Jun 2022
-
-$3.30M(+98.9%)
-$73.77M(+57.0%)
Mar 2022
-
-$287.55M(-402.3%)
-$171.50M(-188.0%)
Dec 2021
$194.91M(-29.0%)
$95.11M(-22.0%)
$194.91M(-47.9%)
Sep 2021
-
$121.97M(+220.7%)
$374.27M(+39.9%)
Jun 2021
-
-$101.03M(-228.1%)
$267.62M(-40.3%)
Mar 2021
-
$78.86M(-71.3%)
$448.34M(+63.3%)
Dec 2020
$274.48M(+765.0%)
$274.48M(+1692.6%)
$274.48M(+98.6%)
Sep 2020
-
$15.31M(-80.8%)
$138.19M(+11.2%)
Jun 2020
-
$79.69M(+183.9%)
$124.28M(+288.0%)
Mar 2020
-
-$95.01M(-168.8%)
-$66.11M(-60.2%)
Dec 2019
-$41.27M(+95.6%)
$138.19M(+9799.1%)
-$41.27M(+91.8%)
Sep 2019
-
$1.40M(+101.3%)
-$505.67M(+37.9%)
Jun 2019
-
-$110.69M(-57.7%)
-$814.74M(+24.5%)
Mar 2019
-
-$70.17M(+78.5%)
-$1.08B(-16.1%)
Dec 2018
-$929.56M(-159.4%)
-$326.21M(-6.0%)
-$929.56M(-41.4%)
Sep 2018
-
-$307.67M(+18.0%)
-$657.57M(-31.5%)
Jun 2018
-
-$375.17M(-572.0%)
-$500.00M(-354.0%)
Mar 2018
-
$79.49M(+246.6%)
-$110.13M(+69.3%)
Dec 2017
-$358.29M(-733.0%)
-$54.21M(+63.9%)
-$358.29M(-26.5%)
Sep 2017
-
-$150.10M(-1121.4%)
-$283.28M(-48.9%)
Jun 2017
-
$14.70M(+108.7%)
-$190.27M(-25.6%)
Mar 2017
-
-$168.68M(-910.9%)
-$151.50M(-367.7%)
Dec 2016
$56.60M(+194.2%)
$20.80M(+136.4%)
$56.60M(-11.2%)
Sep 2016
-
-$57.09M(-206.8%)
$63.76M(-30.4%)
Jun 2016
-
$53.46M(+35.6%)
$91.57M(+259.9%)
Mar 2016
-
$39.43M(+41.0%)
-$57.27M(+4.6%)
Dec 2015
-$60.05M(+27.5%)
$27.96M(+195.5%)
-$60.05M(+56.7%)
Sep 2015
-
-$29.28M(+69.3%)
-$138.80M(-3.6%)
Jun 2015
-
-$95.39M(-360.3%)
-$134.01M(-88.7%)
Mar 2015
-
$36.65M(+172.2%)
-$71.02M(+14.3%)
Dec 2014
-$82.85M(+67.6%)
-$50.79M(-107.4%)
-$82.85M(+29.4%)
Sep 2014
-
-$24.49M(+24.4%)
-$117.33M(+45.7%)
Jun 2014
-
-$32.39M(-230.5%)
-$216.15M(-0.3%)
Mar 2014
-
$24.82M(+129.1%)
-$215.60M(+15.7%)
Dec 2013
-$255.73M(-1520.8%)
-$85.27M(+30.8%)
-$255.73M(-54.6%)
Sep 2013
-
-$123.31M(-287.2%)
-$165.42M(-213.8%)
Jun 2013
-
-$31.84M(-108.0%)
-$52.72M(-1739.8%)
Mar 2013
-
-$15.31M(-404.0%)
$3.21M(-82.1%)
Dec 2012
$18.00M(-83.8%)
$5.04M(+147.5%)
$18.00M(-61.6%)
Sep 2012
-
-$10.61M(-144.0%)
$46.93M(-11.6%)
Jun 2012
-
$24.09M(+4715.7%)
$53.11M(-1.0%)
Mar 2012
-
-$522.00K(-101.5%)
$53.66M(-51.6%)
Dec 2011
$110.90M(+368.0%)
$33.96M(+867.9%)
$110.90M(+59.1%)
Sep 2011
-
-$4.42M(-118.0%)
$69.69M(-53.5%)
Jun 2011
-
$24.64M(-56.6%)
$150.03M(+129.2%)
Mar 2011
-
$56.72M(+883.2%)
$65.45M(+176.2%)
Dec 2010
$23.69M(+111.2%)
-$7.24M(-109.5%)
$23.69M(+50.7%)
Sep 2010
-
$75.91M(+226.7%)
$15.72M(+115.8%)
Jun 2010
-
-$59.94M(-500.7%)
-$99.62M(-45.6%)
Mar 2010
-
$14.96M(+198.3%)
-$68.42M(+67.8%)
Dec 2009
-$212.29M(+9.4%)
-$15.21M(+61.4%)
-$212.29M(+6.9%)
Sep 2009
-
-$39.43M(-37.2%)
-$227.91M(+34.9%)
Jun 2009
-
-$28.73M(+77.7%)
-$350.12M(+0.1%)
Mar 2009
-
-$128.91M(-318.0%)
-$350.42M(-49.6%)
Dec 2008
-$234.25M
-$30.84M(+80.9%)
-$234.25M(-8.5%)
Sep 2008
-
-$161.64M(-456.9%)
-$215.80M(-96.3%)
DateAnnualQuarterlyTTM
Jun 2008
-
-$29.02M(-127.8%)
-$109.93M(-135.3%)
Mar 2008
-
-$12.74M(-2.8%)
-$46.73M(+16.0%)
Dec 2007
-$55.64M(-70.6%)
-$12.39M(+77.8%)
-$55.64M(+44.0%)
Sep 2007
-
-$55.77M(-263.2%)
-$99.40M(-188.6%)
Jun 2007
-
$34.18M(+257.8%)
-$34.45M(+49.0%)
Mar 2007
-
-$21.66M(+61.4%)
-$67.61M(-107.3%)
Dec 2006
-$32.61M(-6138.7%)
-$56.14M(-711.7%)
-$32.61M(-252.1%)
Sep 2006
-
$9.18M(+802.5%)
-$9.26M(-3.0%)
Jun 2006
-
$1.02M(-92.4%)
-$8.99M(-194.8%)
Mar 2006
-
$13.34M(+140.7%)
$9.48M(+1656.3%)
Dec 2005
$540.00K(-99.4%)
-$32.79M(-447.2%)
$540.00K(-99.1%)
Sep 2005
-
$9.44M(-51.6%)
$57.97M(-2.2%)
Jun 2005
-
$19.50M(+343.7%)
$59.27M(+0.4%)
Mar 2005
-
$4.39M(-82.2%)
$59.07M(-29.5%)
Dec 2004
$83.73M(+653.8%)
$24.64M(+129.3%)
$83.73M(+58.6%)
Sep 2004
-
$10.74M(-44.3%)
$52.80M(+80.4%)
Jun 2004
-
$19.29M(-33.6%)
$29.26M(-35.0%)
Mar 2004
-
$29.06M(+561.5%)
$45.01M(+397.7%)
Dec 2003
-$15.12M(+75.0%)
-$6.30M(+50.8%)
-$15.12M(+18.5%)
Sep 2003
-
-$12.79M(-136.5%)
-$18.54M(-197.9%)
Jun 2003
-
$35.04M(+212.8%)
-$6.22M(+90.3%)
Mar 2003
-
-$31.07M(-219.7%)
-$64.13M(-6.2%)
Dec 2002
-$60.37M(+57.9%)
-$9.72M(-1963.5%)
-$60.37M(-13.6%)
Sep 2002
-
-$471.00K(+97.9%)
-$53.14M(+67.6%)
Jun 2002
-
-$22.87M(+16.2%)
-$164.17M(-5.1%)
Mar 2002
-
-$27.31M(-995.3%)
-$156.18M(-8.8%)
Dec 2001
-$143.49M(-50.4%)
-$2.49M(+97.8%)
-$143.49M(+16.7%)
Sep 2001
-
-$111.50M(-649.2%)
-$172.28M(-159.2%)
Jun 2001
-
-$14.88M(-1.8%)
-$66.46M(+20.5%)
Mar 2001
-
-$14.61M(+53.3%)
-$83.55M(+12.4%)
Dec 2000
-$95.38M(-1107.6%)
-$31.29M(-450.4%)
-$95.38M(-15.0%)
Sep 2000
-
-$5.68M(+82.2%)
-$82.93M(-11.2%)
Jun 2000
-
-$31.97M(-20.9%)
-$74.61M(-122.1%)
Mar 2000
-
-$26.44M(-40.3%)
-$33.60M(-325.4%)
Dec 1999
-$7.90M(-186.7%)
-$18.84M(-813.6%)
-$7.90M(-176.4%)
Sep 1999
-
$2.64M(-70.8%)
$10.33M(-39.0%)
Jun 1999
-
$9.04M(+1327.7%)
$16.94M(+498.9%)
Mar 1999
-
-$736.00K(-21.3%)
$2.83M(-69.0%)
Dec 1998
$9.11M(+160.1%)
-$607.00K(-106.6%)
$9.11M(+1659.8%)
Sep 1998
-
$9.24M(+282.2%)
-$584.00K(+96.1%)
Jun 1998
-
-$5.07M(-191.5%)
-$15.13M(-636.2%)
Mar 1998
-
$5.54M(+153.8%)
-$2.06M(+86.5%)
Dec 1997
-$15.16M(-34.5%)
-$10.30M(-94.3%)
-$15.20M(-53.5%)
Sep 1997
-
-$5.30M(-166.3%)
-$9.90M(-595.0%)
Jun 1997
-
$8.00M(+205.3%)
$2.00M(-47.4%)
Mar 1997
-
-$7.60M(-52.0%)
$3.80M(+133.6%)
Dec 1996
-$11.27M(-652.4%)
-$5.00M(-175.8%)
-$11.30M(-156.8%)
Sep 1996
-
$6.60M(-32.7%)
-$4.40M(+83.7%)
Jun 1996
-
$9.80M(+143.2%)
-$27.00M(+20.1%)
Mar 1996
-
-$22.70M(-1294.7%)
-$33.80M(-2153.3%)
Dec 1995
-$1.50M(+83.8%)
$1.90M(+111.9%)
-$1.50M(+54.5%)
Sep 1995
-
-$16.00M(-633.3%)
-$3.30M(-126.8%)
Jun 1995
-
$3.00M(-68.8%)
$12.30M(+1330.0%)
Mar 1995
-
$9.60M(+9500.0%)
-$1.00M(+89.1%)
Dec 1994
-$9.24M(-26.4%)
$100.00K(+125.0%)
-$9.20M(+30.3%)
Sep 1994
-
-$400.00K(+96.1%)
-$13.20M(+14.3%)
Jun 1994
-
-$10.30M(-835.7%)
-$15.40M(-316.2%)
Mar 1994
-
$1.40M(+135.9%)
-$3.70M(+49.3%)
Dec 1993
-$7.31M(-145.1%)
-$3.90M(-50.0%)
-$7.30M(-269.8%)
Sep 1993
-
-$2.60M(-285.7%)
$4.30M(-65.6%)
Jun 1993
-
$1.40M(+163.6%)
$12.50M(+4.2%)
Mar 1993
-
-$2.20M(-128.6%)
$12.00M(-25.9%)
Dec 1992
$16.20M(+137.1%)
$7.70M(+37.5%)
$16.20M(+189.0%)
Sep 1992
-
$5.60M(+522.2%)
-$18.20M(+49.4%)
Jun 1992
-
$900.00K(-55.0%)
-$36.00M(+12.8%)
Mar 1992
-
$2.00M(+107.5%)
-$41.30M(+5.5%)
Dec 1991
-$43.65M
-$26.70M(-118.9%)
-$43.70M(-157.1%)
Sep 1991
-
-$12.20M(-177.3%)
-$17.00M(-254.2%)
Jun 1991
-
-$4.40M(-1000.0%)
-$4.80M(-1100.0%)
Mar 1991
-
-$400.00K
-$400.00K

FAQ

  • What is Ionis Pharmaceuticals, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. annual cash from investing year-on-year change?
  • What is Ionis Pharmaceuticals, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
  • What is Ionis Pharmaceuticals, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. TTM cash from investing year-on-year change?

What is Ionis Pharmaceuticals, Inc. annual cash from investing?

The current annual cash from investing of IONS is -$134.03M

What is the all-time high annual cash from investing for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high annual cash from investing is $274.48M

What is Ionis Pharmaceuticals, Inc. annual cash from investing year-on-year change?

Over the past year, IONS annual cash from investing has changed by +$80.10M (+37.41%)

What is Ionis Pharmaceuticals, Inc. quarterly cash from investing?

The current quarterly cash from investing of IONS is $91.34M

What is the all-time high quarterly cash from investing for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high quarterly cash from investing is $274.48M

What is Ionis Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?

Over the past year, IONS quarterly cash from investing has changed by +$432.13M (+126.80%)

What is Ionis Pharmaceuticals, Inc. TTM cash from investing?

The current TTM cash from investing of IONS is $209.94M

What is the all-time high TTM cash from investing for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high TTM cash from investing is $448.34M

What is Ionis Pharmaceuticals, Inc. TTM cash from investing year-on-year change?

Over the past year, IONS TTM cash from investing has changed by +$438.89M (+191.70%)
On this page